If you liked this article you might like

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis

These Biotech Stocks are BOOMING

Valeant and Teva Share Similar Ambitions With Similar Pitfalls

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire